The Risk of Endometrial and Breast Cancer After Estrogen Treatment: A review of epidemiological studies

References

• Antunes C MF, Stolley P D., Rosenshein N B., Davies J L., Tonascia J A., Brown C, Burnett L, Rutledge A, Pokempner K, Garcia R. Endometrial cancer and estrogen use: Report of a large case-control study. N Engl J Med 1979; 300: 9
   PubMed Web of Science ®Google Scholar
• Boston Collaborative Drug Surveillance Program. Surgically confirmed gallbladder disease, venous thromboembolism and breast tumors in relation to postmenopausal estrogen therapy. N Engl J Med 1974; 290: 15
   PubMed Web of Science ®Google Scholar
• Brinton L A., Williams R R., Hoover R N., Stegens N L., Feinleib M, Fraumeni J F. Breast cancer risk factors among screening program participants. J Nat Cancer Inst 1979; 62: 37
   PubMedGoogle Scholar
• Byrd B F., Burch J C., Vaughn W K. The impact of long term estrogen support after hysterectomy. A report of 1016 cases. Ann Surg 1977; 185: 574
   PubMed Web of Science ®Google Scholar
• Casagrande J, Gerkins V, Henderson B E., Mack T, Pike M C. Brief communication: Exogenous estrogens and breast cancer in women with natural menopause. J Nat Cancer Inst 1976; 56: 839
   Google Scholar
• Collins J, Donner A, Allen L H., Adams O. Oestrogen use and survival in endometrial cancer. Lancet Nov 1980; 961
   Google Scholar
• Collins J. Oestrogen and endometrial cancer: a reappraisal. J R Soc Med 1981; 74: 403
   PubMed Web of Science ®Google Scholar
• Craig T J., Comstock G W., Geisen P B. Epidemiologic comparison of breast cancer patients with early and late onset of malignancy and general population controls. J Nat Cancer Inst 1974; 53: 1577
   PubMedGoogle Scholar
• Cramer D. Recent advances in endometrial neoplasia. Acta Cytol 1980; 24: 478
   Google Scholar
• Davies J L., Rosenshein N B., Antunes C MF, Stolley P D. A review of the risk factors for endometrial carcinoma. Obstet Gynecol Surv 1981; 36: 107
   PubMedGoogle Scholar
• Gambrell R D. Preventing endometrial cancer with progestin. Contemp Obstet Gyn 1981; 17: 133
   Google Scholar
• Gordon G S., Greenberg B G. Exogenous estrogens and endometrial cancer. Postgrad Med 1976; 59: 66
   Google Scholar
• Gray L A., Christopherson W M., Hoover R N. Estrogens and endometrial carcinoma. Obstet Gynecol 1977; 49: 385
   PubMed Web of Science ®Google Scholar
• Greenwald P, Nasca P C., Caputo T A., Janerich D T. Cancer risks from estrogen intake. NY State J Med 1977; 77: 1069
   Google Scholar
• Hammond C B., Jelovsek F R., Lee K L., Creasman W T., Parker R T. Effects of long-term estrogen replacement therapy, II. Neoplasia. Am J Obstet Gynecol 1979; 133: 537
   PubMed Web of Science ®Google Scholar
• Henderson B E., Powell D, Rosario I, Keys C, Hanisch R, Young M, Casagrande J, Gerkins V, Pike M C. An epidemiologic study of breast cancer. J Nat Cancer Inst 1974; 53: 609
   PubMedGoogle Scholar
• Horwitz R I., Feinstein A R. Alternative analytical methods for case-control studies of estrogens and endometrial cancer. N Engl J Med 1978; 299: 1089
   Google Scholar
• Hoover R, Gray L A., Cole P, MacMahon B. Menopausal estrogens and breast cancer. New Engl J Med 1976; 295: 401
   PubMed Web of Science ®Google Scholar
• Hoover A, Finkle D F., Azevedo D, Milne K. Conjugated estrogens and breast cancer risk in women. J Nat Cancer Inst 1981; 67: 815
   PubMedGoogle Scholar
• Hulka B S., Fowler W C., Kaufman D G., Grimson R C., Greenberg B G., Hogue C, Jr, Berger G S., Pulliam C C. Estrogen and endometrial cancer: Cases and two control groups from North Carolina. Am J Obstet Gynecol 1980; 137: 92
   PubMed Web of Science ®Google Scholar
• Hulka B S. Effect of exogenous estrogen on postmenopausal women: The epidemiologic evidence. Obstet Gynecol Surv 1980; 35(6)389
   Google Scholar
• Jick H, Walker A M., Watkins R N. Replacement estrogens and breast cancer. Am J Epidemiol 1980; 112: 586
   Google Scholar
• Judd H, Cleary R, Creasman W, Figge D, Kase W, Rosenwaks Z, Tagatz G. Estrogen replacement therapy. Obstet Gynecol 1981; 58: 267
   PubMed Web of Science ®Google Scholar
• Laurizen C, Wolf A S., Strabl M. Endometrial Cancer, M G. Brush, et al. Baillière Tindall, London 1978; 39
   Google Scholar
• MacMahon B. Risk factors for endometrial cancer. Gynecol Oncol 1974; 2: 122
   PubMedGoogle Scholar
• Mack T M., Henderson B E., Gerkins V R., Arthur M, Baptista J, Pike M C. Reserpine and breast cancer in a retirement community. New Engl J Med 1975; 292: 1366
   PubMed Web of Science ®Google Scholar
• Mack T M., Pike M C., Henderson B E., Pfeffer R I., Gerkins V R., Arthur M, Brown S E. Estrogens and endometrial cancer in a retirement community. N Engl J Med 1976; 294: 1262
   PubMed Web of Science ®Google Scholar
• McDonald T W., Annegers J F., O'Fallon W M., Dockerty M B., Malkasian G D., Kurland L T. Exogenous estrogen and endometrial carcinoma: Case-control and incidence study. Am J Obstet Gynecol 1977; 127: 572
   PubMed Web of Science ®Google Scholar
• Fakta N M. Östrogenförbrukning i Finland—komplettering av NM fakta. Nord Med 1977; 928
   Google Scholar
• Paterson M EL, Wade-Evans T, Sturdee D W., Thom M H., Studd J WW. Endometrial disease after treatment with oestrogens and progestogens in the climacteric. Br Med J 1980; iii: 822
   Google Scholar
• Persson I, Adami H O., Johansson E DB, Lindberg B S., Manell P, Westerholm B. Cohort study of oestrogen treatment and the risk of endometrial cancer: Evaluation of method and its applicability. Eur J Clin Pharmacol 1983; 25: 625
   PubMed Web of Science ®Google Scholar
• Persson I, Adami H O., Lindberg B S., Johansson E DB, Manell P. Practice and patterns of estrogen treatment in climacteric women in a Swedish population: A descriptive epidemiological study. Part I. Acta Obstet Gynecol Scand 1983; 62: 289
   PubMed Web of Science ®Google Scholar
• Persson I, Adami H O., Lindberg B S., Johansson E DB, Manell P. Characteristics of estrogen-treated women: A descriptive edidemiological study of a Swedish population. Part II. Acta Obstet Gynecol Scand 1983; 62: 297
   Web of Science ®Google Scholar
• Persson I. Climacteric treatment with estrogens and estrogen - progestogen combinations: The risk of endometrial neoplasia. Results of a cohort study. Thesis, University of Uppsala. 1983
   Google Scholar
• Ross K, Paganini-Hill A, Gerkins R, Mack T M. A case-control study of menopausal estrogen therapy and breast cancer. JAMA 1980; 243: 1635
   PubMed Web of Science ®Google Scholar
• Salmi T. Risk factors in endometrial carcinoma with special reference to the use of estrogens. Acta Obstet Gynecol Scand 1979, Suppl. 86
   Google Scholar
• Sartwell P E., Arthes F G., Tonascia J A. Exogenous hormones, reproductive history, and breast cancer. J Nat Cancer Inst 1977; 59: 1589
   PubMedGoogle Scholar
• Smith D C., Prentice R, Thomson D J., Herrman W L. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 1975; 293: 1164
   PubMed Web of Science ®Google Scholar
• Utian W H. Current status of menopause and postmenopausal estrogen therapy. Obstet Gynecol Surv 1977; 32(4)193
   Google Scholar
• Weiss N S., Szekely D R., English D R., Schweid A I. Endometrial cancer in relation to patterns of menopausal estrogen use. J Am Med Assoc 1979; 242: 261
   PubMed Web of Science ®Google Scholar
• Wynder E L., MacCornack F A., Stellman S D. The epidemiology of breast cancer in 785 United States Caucasian women. Cancer 1978; 41: 2341
   PubMed Web of Science ®Google Scholar
• Ziel H K., Finkle W D. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 1976; 293: 1167
   Google Scholar
• Ziel H K. Estrogen's role in endometrial cancer. Obstet Gynecol 1982; 60(4)509
   Google Scholar
• Öbrink A, Bunne C, Tjernberg B. Estrogen regimen of women with endometrial carcinoma. Acta Obstet Gynecol Scand 1981; 60: 193
   Google Scholar